Mayo Risk Score is not predictive of Cholangiocarcinoma associated with Primary Sclerosing Cholangitis.

被引：1
|
作者：
Olivera, MA
McCashland, TM
Ruby, L
Rouillard, S
Somberg, K
Reddy, R
机构：
[1] Univ Nebraska, Med Ctr, Liver Transplant Unit, Lincoln, NE 68583 USA
[2] Univ Calif San Francisco, UNMC, San Francisco, CA 94143 USA
[3] UCSF, Ctr Liver Dis, Miami, FL USA
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)85341-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
L0483
引用
收藏
页码：A1316 / A1316
页数：1
相关论文
共 50 条
  • [1] Incidence or cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Pasha, TM
    Petz, J
    Ludwig, J
    Therneau, TM
    Benson, JT
    Malinchoc, M
    Dickson, ER
    Lindor, KD
    [J]. HEPATOLOGY, 1997, 26 (04) : 165 - 165
  • [2] Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
    Ahrendt, SA
    Pitt, HA
    Nakeeb, A
    Klein, AS
    Lillemoe, KD
    Kalloo, AN
    Cameron, JL
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A1374 - A1374
  • [3] Risk Factors of Intrahepatic Cholangiocarcinoma in Absence of Viral Hepatitis and Primary Sclerosing Cholangitis.
    Abdelhakeem, Ahmed
    Rallapalli, Vijayashri
    Ali, Reham Abdelwahab Hassan
    Javle, Milind
    Hassan, Manal M.
    [J]. HEPATOLOGY, 2018, 68 : 546A - 547A
  • [4] Long Term Risk of Cholangiocarcinoma after Liver Transplantation for Primary Sclerosing Cholangitis.
    Raju, Ravish Sanghi
    Brooke-Smith, Mark
    Dolan, Paul
    Kow, Lilian
    Gan, Susan
    Padbury, Robert T. A.
    Chen, John W. C.
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S190 - S190
  • [5] Colectomy is associated with development of hepatobiliary malignancy but not cholangiocarcinoma in patients with Primary Sclerosing Cholangitis.
    Williamson, Kate D.
    Kozak, Ladislav
    Al Mamari, Said
    Halliday, John
    Chapman, Roger W.
    [J]. HEPATOLOGY, 2015, 62 : 518A - 518A
  • [6] Independent validation of Mayo natural history model for primary sclerosing cholangitis.
    Kim, WR
    Lindor, KD
    Broome, U
    Benson, JT
    Therneau, TM
    Dickson, ER
    [J]. HEPATOLOGY, 1999, 30 (04) : 477A - 477A
  • [7] PRURITUS, BUT NOT MAYO RISK SCORE IS ASSOCIATED WITH SEVERELY IMPAIRED QUALITY OF LIFE IN PRIMARY SCLEROSING CHOLANGITIS
    Gotthardt, Daniel
    Bruhin, Miriam
    Schellberg, Dieter
    Weiss, Karl Heinz
    Stremmel, Wolfgang
    Juenger, Jana
    Sauer, Peter
    [J]. HEPATOLOGY, 2009, 50 (04) : 1006A - 1006A
  • [8] Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
    Batheja, N
    Saxena, R
    Suriawinata, A
    Ionescu, G
    Thung, S
    [J]. MODERN PATHOLOGY, 1998, 11 (01) : 150A - 150A
  • [9] Primary sclerosing pancreatitis and cholangitis.
    Ashizawa, N
    Fukuhara, H
    Hamamoto, N
    Moriyama, N
    Kazumori, H
    Arima, N
    Watanabe, M
    Kinoshita, Y
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A448 - A448
  • [10] The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis
    Kim, WR
    Lindor, KD
    Poterucha, JJ
    Benson, JT
    Therneau, TM
    Dickson, ER
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A1274 - A1274
12345